WILMINGTON, DE / ACCESSWIRE / September 20, 2022 / Transparency Market Research Inc. - Growing number of patients with life-threatening bleeding due to effects of anticoagulants is steering the use of anticoagulant reversal drugs. Rise in use of anticoagulant therapy in strokes and systemic embolism will enrich the future market outlook for anticoagulant reversal drugs. The anticoagulant reversal drugs market is projected to surpass value of US$ 2.3 Bn by 2031.
Extensive sales of products through hospital pharmacies have made the segment to account for the largest revenue share in the anticoagulant reversal drugs market in 2021. The anticoagulant reversal drugs market demand analysis found that enormous use of direct-acting oral anticoagulants (DOACs) and warfarin has spurred the prospects of anticoagulant reversal drugs market.
Vitamin K held the major share for anticoagulant reversal drugs market in 2021, as it isfshare the most widely preferred reversal agent for warfarin medications. Prevalent use of anticoagulant therapies in reducing the risks of devastating strokes presents value-grab opportunity for firms in anticoagulant reversal drugs market. Recent anticoagulant reversal drugs market demand analysis indicates that there is an unmet need for specific reversal agents in some indications.
Get Exclusive PDF Sample Copy of Anticoagulant Reversal Drugs Market Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=40970
Key Findings of Anticoagulant Reversal Drugs Market Study
- Substantial Demand for Reversal Agents in Life-Threatening Bleeding Conditions Propelling Revenue Streams: Anticoagulant therapy is used in acute life-threatening or uncontrolled bleeding in several surgical procedures. The trend is impelling the demand for reversal agents, thereby creating vast lucrative avenues for market players.
- Use of Anticoagulant Reversal Drugs in ICH and GI Hemorrhages Presents Massive Revenue Potential: The products find widespread use in emergency reversal of anticoagulation in various types of hemorrhage, notably in fatal bleeding and intracranial hemorrhage (ICH). Players are grabbing the opportunities to grow market share for anticoagulant reversal drugs. Substantial use of DOAC in GI hemorrhages has spurred the revenue streams.
- Prevalence of Atrial Fibrillation Spurring Need for Reversal of Anticoagulation: Rise in use of anticoagulant therapies in patients with atrial fibrillation particularly warfarin is bolstering the revenue potential for players in the anticoagulant reversal drugs market. Emerging anticoagulant options for the patient population will open up new revenue streams.
Ask for References -https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=40970
Anticoagulant Reversal Drugs Market: Key Drivers
- Rise in number of surgical procedures in hospitals where anticoagulant therapy is used is a key driver for the anticoagulant reversal drugs market. Emergency reversal of anticoagulation has become imperative for patients with strokes and atrial fibrillation.
- Rapidly increasing use of direct-acting oral anticoagulants (DOACs) has spurred the need for reversal drugs. Focus on making the therapies more affordable in hospital settings shas led to the adoption of new technology add-on payment (NTAP) status in the U.S.
Anticoagulant Reversal Drugs Market: Regional Growth Dynamics
- North America held the major market share in 2021. The region has witnessed vast revenue streams on the back of rise in number of new product approvals and massive pace of commercialization of these in the U.S. and Canada.
- Opportunities in Asia Pacific market are rising at a remarkable pace. Rise in demand for products for life-threatening bleeding conditions in arterial fibrillation and adoption of products for elderly patients will spur revenue generation during the forecast period. The vast pace of commercialization of products in China and Japan is underpinning the revenue potential.
Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=40970
Anticoagulant Reversal Drugs Market: Key Players
The competition landscape of the market is characterized by high degree of consolidation. Some of the key players in the market are Perosphere, Portola Pharmaceuticals, Octapharma AG, CSL Limited, Boehringer Ingelheim, Amneal Pharmaceuticals, Inc., Fresenius Kabi AG, Pfizer, Inc., and Bausch Health Companies, Inc.
Anticoagulant Reversal Drugs Market Segmentation
- Product
- Prothrombin Complex Concentrates
- Vitamin K
- Protamine
- Tranexamic Acid
- Idarucizumab
- AndeXXa
- Others
- Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Modernization of healthcare in terms of both infrastructure and services have pushed the healthcare industry to new heights, Stay Updated with Latest Healthcare Research Reports by Transparency Market Research:
Macular Degeneration Treatment Market: The global macular degeneration treatment market is anticipated to reach more than US$ 21.1 Bn by the end of 2031 with a CAGR of 8.8% from 2022 to 2031.
PET Radiotracer Market: The global PET radiotracer market is anticipated to reach more than US$ 3.2 Bn by the end of 2031 with a CAGR of 8.5% from 2022 to 2031.
Gemcitabine HCL Market: The global gemcitabine HCl market is anticipated to reach more than US$ 1.3 Bn by 2031 with a CAGR of 7.8% from 2022 to 2031.
Atopic Dermatitis Drugs Market: The global atopic dermatitis drugs market is anticip.ated to reach more than US$ 29.4 Bn by the end of 2031 with a CAGR of 14.7% from 2022 to 2031.
Red Biotechnology Market: The global red biotechnology market is anticipated to reach more than US$ 609.6 Bn by the end of 2031 with a CAGR of 5.6% from 2022 to 2031.
Epilepsy Therapeutics Market: The global epilepsy therapeutics market is anticipated to reach more than US$ 14.9 Bn by the end of 2031 with a CAGR of 3.5% from 2022 to 2031.
Joint Pain Injections Market: The global joint pain injections market is anticipated to reach more than US$ 9.8 Bn by the end of 2031 with a CAGR of 7.8% from 2022 to 2031.
Human Microbiome Market: The human microbiome market in India is anticipated to reach more than US$ 282 Mn by the end of 2031 with a CAGR of 6.9% from 2022 to 2031.
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ
Contact:
Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: [email protected]
SOURCE: Transparency Market Research Inc.